bpc-157 human clinical trials evidence review 2024 2025 Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System BPC-157 & The Gut-Brain Axis:

Ulanovskaya OA, Zuhl AM, Cravatt BF

While most are mild , practitioners should be aware of both common and rare reactions: Common : mild soreness at the injection site, flushing, or temporary nausea

Marketing Authorization Holder GERDA LABORATORIES 24 RUE ERLANGER 75016 PARIS Operator of the marketing authorization GERDA LABORATORIES 24 RUE ERLANGER 75016 PARIS Maker DELPHARM TOURS LA BARAUDIERE 37170 CHAMBRAY LES TOURS or HAUPT PHARMA LIVRON 1 STREET COUNTY SINARD 26250 LIVRON-SUR-DROME Names of the drug in the member states of the European Economic Area Not applicable

Other symptoms to note : With rosacea, skin might feel rough, bumpy, or warm to the touch

Severe GI reactions (peptic ulcer, GI bleeding, and GI perforation) occurred in 0.4% to 4.6% of patients without a history of a peptic ulcer or bleed and in 2.1% to 15.4% of patients with a history of a peptic ulcer or bleed